IN8bio Beheer
Beheer criteriumcontroles 2/4
Momenteel beschikken wij niet over voldoende informatie over de CEO.
Belangrijke informatie
William Ho
Algemeen directeur
US$1.9m
Totale compensatie
Percentage CEO-salaris | 30.8% |
Dienstverband CEO | 9yrs |
Eigendom CEO | 6.0% |
Management gemiddelde ambtstermijn | 5yrs |
Gemiddelde ambtstermijn bestuur | 4.2yrs |
Recente managementupdates
Recent updates
IN8bio (NASDAQ:INAB) Will Have To Spend Its Cash Wisely
Aug 06We're Keeping An Eye On IN8bio's (NASDAQ:INAB) Cash Burn Rate
Apr 03Companies Like IN8bio (NASDAQ:INAB) Could Be Quite Risky
Nov 04Is IN8bio (NASDAQ:INAB) In A Good Position To Invest In Growth?
Jan 26Here's Why We're Watching IN8bio's (NASDAQ:INAB) Cash Burn Situation
Oct 12IN8bio gains 53% as H.C. Wainwright initiates with Buy
Aug 30IN8bio raises additional funds from underwriter of stock offering
Aug 19IN8bio prices $10.25M stock offering
Aug 12We're Keeping An Eye On IN8bio's (NASDAQ:INAB) Cash Burn Rate
Jun 04IN8bio (NASDAQ:INAB) Is In A Good Position To Deliver On Growth Plans
Feb 13IPO Update: IN8bio Aims For Downsized IPO
Jul 29Analyse CEO-vergoeding
Datum | Totale vergoeding | Salaris | Bedrijfswinsten |
---|---|---|---|
Jun 30 2024 | n/a | n/a | -US$32m |
Mar 31 2024 | n/a | n/a | -US$31m |
Dec 31 2023 | US$2m | US$572k | -US$30m |
Sep 30 2023 | n/a | n/a | -US$30m |
Jun 30 2023 | n/a | n/a | -US$30m |
Mar 31 2023 | n/a | n/a | -US$30m |
Dec 31 2022 | US$2m | US$550k | -US$29m |
Sep 30 2022 | n/a | n/a | -US$27m |
Jun 30 2022 | n/a | n/a | -US$23m |
Mar 31 2022 | n/a | n/a | -US$18m |
Dec 31 2021 | US$2m | US$446k | -US$15m |
Sep 30 2021 | n/a | n/a | -US$12m |
Jun 30 2021 | n/a | n/a | -US$11m |
Mar 31 2021 | n/a | n/a | -US$11m |
Dec 31 2020 | US$1m | US$279k | -US$10m |
Sep 30 2020 | n/a | n/a | -US$9m |
Jun 30 2020 | n/a | n/a | -US$8m |
Mar 31 2020 | n/a | n/a | -US$6m |
Dec 31 2019 | US$214k | US$214k | -US$6m |
Compensatie versus markt: De totale vergoeding ($USD 1.85M ) William } ligt boven het gemiddelde voor bedrijven van vergelijkbare omvang in de US markt ($USD 653.78K ).
Compensatie versus inkomsten: De vergoeding van William is gestegen terwijl het bedrijf verliesgevend is.
CEO
William Ho (47 yo)
9yrs
Tenure
US$1,854,166
Compensatie
Mr. William Ho, also known as Will, is the Co-Founder of IN8bio, Inc. and has been President, Chief Executive Officer and Director since November 2015 and had been its Chief Financial Officer since October...
Leiderschapsteam
Naam | Positie | Tenure | Compensatie | Eigendom |
---|---|---|---|---|
Co-Founder | 9yrs | US$1.85m | 5.99% $ 802.9k | |
CFO & Secretary | 3.8yrs | US$914.84k | 0.11% $ 14.9k | |
Executive VP | 6yrs | US$918.75k | 0.22% $ 29.0k | |
Chief Operating Officer | 3.9yrs | US$934.68k | 0.092% $ 12.3k |
5.0yrs
Gemiddelde duur
44.5yo
Gemiddelde leeftijd
Ervaren management: Het managementteam van INAB wordt beschouwd als ervaren (gemiddelde ambtstermijn 5 jaar).
Bestuursleden
Naam | Positie | Tenure | Compensatie | Eigendom |
---|---|---|---|---|
Co-Founder | 9yrs | US$1.85m | 5.99% $ 802.9k | |
Independent Director | 5.3yrs | US$195.42k | 1.33% $ 178.4k | |
Independent Chairman of the Board | 4.2yrs | US$256.42k | 0.61% $ 81.6k | |
Independent Director | 3.3yrs | US$172.92k | 7.14% $ 957.0k | |
Member of Scientific Advisory Board | no data | geen gegevens | geen gegevens | |
Independent Director | 4.2yrs | US$163.67k | 0% $ 0 | |
Independent Director | 3.3yrs | US$181.42k | 0.017% $ 2.2k | |
Member of Scientific Advisory Board | no data | geen gegevens | geen gegevens | |
Member of Scientific Advisory Board | no data | geen gegevens | geen gegevens | |
Member of Scientific Advisory Board | no data | geen gegevens | geen gegevens | |
Member of Scientific Advisory board | no data | geen gegevens | geen gegevens | |
Member of Scientific Advisory Board | 2.2yrs | geen gegevens | geen gegevens |
4.2yrs
Gemiddelde duur
47yo
Gemiddelde leeftijd
Ervaren bestuur: De raad van bestuur van INAB wordt beschouwd als ervaren (gemiddelde ambtstermijn 4.2 jaar).